Cargando…
Safety and Efficacy of Losartan 50 mg in Reducing Blood Pressure among Patients with Post-Dialysis Euvolemic Hypertension: A Randomized Control Trial
The aim of current study was to assess the effectiveness of losartan 50 mg in reducing blood pressure among post-dialysis euvolemic hypertensive patients, observing their survival trends and adverse events during the course of study. A multicentre, prospective, randomised, single-blind trial was con...
Autores principales: | Aftab, Raja Ahsan, Khan, Amer Hayat, Adnan, Azreen Syazril, Sulaiman, Syed Azhar Syed, Khan, Tahir Mehmood |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5735086/ https://www.ncbi.nlm.nih.gov/pubmed/29255272 http://dx.doi.org/10.1038/s41598-017-17437-4 |
Ejemplares similares
-
Efficacy of Losartan in the management of Post-Dialysis Euvolemic Hypertension (HELD-Trial): A Single-Blind Randomized Control Trial
por: Aftab, Raja Ahsan, et al.
Publicado: (2016) -
Protocol of randomized control trial for effectiveness of angiotensin receptor blockers on blood pressure control among euvolemic hypertensive hemodialysis patients
por: Aftab, Raja Ahsan, et al.
Publicado: (2017) -
Hypertension control among euvolemic hypertensive hemodialysis patients in Malaysia: a prospective follow-up study
por: Khan, Amjad, et al.
Publicado: (2019) -
Prevalence and predictors of depression among hemodialysis patients: a prospective follow-up study
por: Khan, Amjad, et al.
Publicado: (2019) -
Management of Patient Care in Hemodialysis While Focusing on Cardiovascular Disease Events and the Atypical Role of Hyper- and/or Hypotension: A Systematic Review
por: Khan, Amjad, et al.
Publicado: (2016)